| Date Filed | Type | Description |
| 11/27/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/27/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/24/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 11/17/2020 |
8-K
| Resignation/termination of a director |
| 11/17/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/17/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/17/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/15/2020 |
GN
| MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten |
| 11/13/2020 |
GN
| MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020 |
| 11/11/2020 |
GN
| MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy |
| 11/10/2020 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 1.9% stake in MyoKardia Inc |
| 11/10/2020 |
SC 13G/A
| FMR LLC reports a 0% stake in MYOKARDIA INC |
| 11/10/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 11/05/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/05/2020 |
8-K
| Quarterly results |
| 11/05/2020 |
GN
| MyoKardia Reports Third Quarter 2020 Financial Results |
| 11/04/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/04/2020 |
GN
| MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program |
| 11/04/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/30/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/28/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/21/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, MYOK, and CBMG Mergers |
| 10/19/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, CBMG, CIT, and STND Mergers |
| 10/19/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/19/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Montage Resources Corporation (NYSE: MR), MyoKardia, Inc. (NASDAQ: MYOK), Standard AVB Financial Corp. (NASDAQ GS: STND), and Virtusa Corporation (NASDAQ: VRTU) |
| 10/09/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, MOBL, WPX, and STND Mergers |
| 10/06/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/05/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of MyoKardia, Inc. Buyout |
|